Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: beta-Erythroidine hydrochloride
RN: 596-11-2
UNII: 18N5E1RCCV
InChIKey: PLENFHSJZZDRNT-LINSIKMZSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C16-H19-N-O3.Cl-H

Molecular Weight

  • 309.791
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • beta-Erythroidine hydrochloride

Synonyms

  • 16(15H)-Oxaerythrinan-15-one, 1,2,6,7-tetradehydro-14,17-dihydro-3-methoxy-, hydrochloride
  • UNII-18N5E1RCCV

Systematic Name

  • beta-Erythroidine, hydrochloride

Registry Numbers

CAS Registry Number

  • 596-11-2

FDA UNII

  • 18N5E1RCCV

Related Registry Number

  • 466-81-9 (Parent)

System Generated Number

  • 0000596112

Molecular Formulas

Molecular Formula

  • C16-H19-N-O3.Cl-H

Molecular Formula Fragments

  • C16-H19-N-O3
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C16H19NO3.ClH/c1-19-13-3-2-12-5-7-17-6-4-11-10-20-15(18)8-14(11)16(12,17)9-13;/h2-3,5,13H,4,6-10H2,1H3;1H/t13-,16-;/m0./s1

InChIKey

PLENFHSJZZDRNT-LINSIKMZSA-N

Smiles

C=12[C@@]34[N@H+](CC=C3C=C[C@@H](C4)OC)CCC1COC(C2)=O.[ClH-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
cat LDLo oral 30mg/kg (30mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
cat LDLo subcutaneous 20mg/kg (20mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
dog LD50 intravenous 8800ug/kg (8.8mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 82, Pg. 266, 1944.
frog LDLo parenteral 300mg/kg (300mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
mouse LD50 oral 75mg/kg (75mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
mouse LD50 subcutaneous 48mg/kg (48mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
rabbit LD50 intravenous 8600ug/kg (8.6mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 82, Pg. 266, 1944.
rabbit LDLo oral 200mg/kg (200mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
rabbit LDLo subcutaneous 50mg/kg (50mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
rat LD50 intravenous 39300ug/kg (39.3mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 82, Pg. 266, 1944.
rat LD50 oral 510mg/kg (510mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
rat LD50 subcutaneous 1260mg/kg (1260mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA Journal of Pharmacology and Experimental Therapeutics. Vol. 80, Pg. 39, 1944.
rat LDLo intraperitoneal 150mg/kg (150mg/kg) GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Journal of Pharmacology and Experimental Therapeutics. Vol. 75, Pg. 270, 1942.